Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

89.79
-0.0400-0.04%
Post-market: 89.790.00000.00%19:52 EDT
Volume:2.82M
Turnover:253.16M
Market Cap:51.77B
PE:52.23
High:90.37
Open:89.89
Low:88.79
Close:89.83
52wk High:96.29
52wk Low:72.30
Shares:576.54M
Float Shares:575.03M
Volume Ratio:1.01
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.72
EPS(LYR):1.83
ROE:9.18%
ROA:8.37%
PB:4.88
PE(LYR):48.99

Loading ...

Edwards Lifesciences (EW) Faces FTC Penalty, Is The Stock Still Cheap?

Simply Wall St.
·
Jul 18

Edwards Lifesciences Corp. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 18

Edwards Lifesciences Expands Pediatric Heart Portfolio With Autus Valve Access Study

TIPRANKS
·
Jul 18

QTREX Quantum Appoints Ex-nano Dimension R&D Chief Chappel-ram as Independent Director

Reuters
·
Jul 17

How Investors Are Reacting To Edwards Lifesciences (EW) Record FTC HSR Penalty And Added Oversight

Simply Wall St.
·
Jul 17

Edwards Lifesciences is Maintained at Hold by Truist Securities

Dow Jones
·
Jul 17

Abbott Raises 2026 Profit Forecast on Heart Device Strength

Reuters
·
Jul 16

Edwards Lifesciences to Host Quarterly Earnings Conference Call

Reuters
·
Jul 16

Earning Preview: Edwards Lifesciences this quarter’s revenue is expected to increase by 14.19%, and institutional views are bullish

Earnings Agent
·
Jul 16

Jenscare Completes First Implants in FDA Pivotal Trial for Lux-valve Plus Tricuspid Valve System

Reuters
·
Jul 16

Mizuho Adjusts Price Target on Edwards Lifesciences to $105 From $100, Maintains Outperform Rating

MT Newswires Live
·
Jul 15

Movement Alert|Edwards Lifesciences Falls 3.21% in Regular Trading, Trading at $87.355

Market Focus
·
Jul 15

Analysts See Risks for Elective-procedure Medtechs After HCA Cuts Profit Forecast

Reuters
·
Jul 15

Edwards Lifesciences Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 15

Movement Alert|Edwards Lifesciences Falls 3.28% in Regular Trading, Trading at $89.91

Market Focus
·
Jul 14

Edwards Lifesciences, Genesis Medtech to Pay Combined $12M to Settle FTC Charges

Dow Jones
·
Jul 14

Edwards Lifesciences is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 13

RBC Raises Price Target on Edwards Lifesciences to $110 From $100, Keeps Outperform Rating

MT Newswires Live
·
Jul 13

Edwards Lifesciences CVP Daniel J. Lippis Disposes of 619 Common Shares Worth $56,762.3

Reuters
·
Jul 11

Edwards Lifesciences Corp. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 09